Both in Pharmaceuticals
Lite Strategy vs Grace Therapeutics
Over the past year LITS returned −41.9% and GRCE returned −41.3%; their daily moves had a correlation of 0.08.
LITS −41.9% GRCE −41.3%Growth of $1, one year, split-adjusted
| Metric | LITS | GRCE |
|---|---|---|
| Price | $1.15 | $1.89 |
| Market cap | $35.0M | $39.8M |
| Today | −3.77% | −3.08% |
| 1 month | +10.6% | −11.3% |
| 6 months | −2.5% | −58.9% |
| Year to date | −12.9% | −45.4% |
| 1 year | −46.0% | −39.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.7M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 76.9% | 38.1% |
| Short % of float | 0.6% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).